top of page
wire_frame_cardio_system.png

Introducing a New Category
Of Heart Failure Treatment

CRPA :
Cardio-Respiratory
Physiological Assist 

Heart failure remains one of the largest unmet needs in medicine, affecting 6.7 million people in the United States and 64 million worldwide. Patients face a relentless cycle of hospital readmissions, with 25 percent readmitted within 30 days of discharge.

Heart failure is the leading cause of hospitalization among U.S. Medicare beneficiaries, creating an economic burden exceeding $30 billion annually and projected to reach $70 billion by 2030.

Levron Medical introduces a novel and fresh approach to the treatment of Heart Failure, with elegance and simplicity like no other. 

Events

2026

HRS Conference - April 23-26, 2026 - Chicago, IL,USA

​​

A Novel Cardio-Respiratory Physiological Assist Technology That Synchronizes The Heart Rhythm To The Respiratory Dynamic For Alleviating Pulmonary Congestion In Patients With Chronic Heart Failure, First-In-Human Study

​

THT_2026.png

2025

CSI-DHF2025.png
ICI2025_clean_crop.png
cropped-FOX40-Logo-5_edited.jpg

News & Press release

2025

MPO.png

2024

WhatsApp Image 2024-12-11 at 14.32.56_64e23768.jpg
PRWeb_edited.jpg

Our Team

Amir Ronen is an entrepreneur and  a seasoned executive in the Israeli hi-tech scene. A co-founder and CEO for 15 years in the Heart Failure medical device space, and previously a VP in NASDAQ traded companies all which have been merged and acquired (Sensible Medical $150M; M-Systems $1.4B; Saifun $384M). Amir holds a BsC in Electronic Engineering from the Technion and an MBA from Kellogg IMBA.

Prof. Landesberg is the former dean of the biomedical engineering faculty at the Technion and former president of the International Society for Heart Research Israel group. Prof. Landesberg holds a Phd. In biomedical engineering and an M.D. Cum-Laude both from the Technion

Dr. Eckhouse is the founder and chairman of Alon MedTech ventures, a major player in the Israeli medical eco system, founded and invested in 20+ companies. such as Syneron Medical (acquired for $400M) and Ventor technologies (acquired for $325M)

Dr. Livneh is an R&D executive with extensive experience in preclinical and clinical cardiovascular research and development, specializing in real-time biomedical signal processing, machine learning and data science. Dr. Livneh holds a PhD. in Biomedical Engineering from the Technion, an MSc. in Electrical Engineering from Tel-Aviv University, and a BSc. in Electrical Engineering from the Technion.

Anat is a Certified Public Accountant with extensive experience driving financial leadership, corporate finance, and strategic planning for fast-growing venture capital, high-tech, and international companies. Anat holds a B.A. in Accounting and an M.B.A. in Taxation from The College of Management Academic Studies.

Itzik brings over 25 years of senior executive experience in medical device startups, specializing in multidisciplinary products, software and algorithms.

Prior to joining Levron, Itzik served as CTO and Head of Algorithm Development at NewPace, VP of R&D, Product, and Operations at Trig Medical and System Application Software Group Manager at Mediguide. Itzik holds a B.Sc. in Computer Engineering from the Technion - Israel Institute of Technology.

Yael brings two decades of experience as clinical director and clinical trial management, regulation and quality assurance.

Hani has more than 40 years of experience in the fields of bookkeeping, payroll, and finance. Hani is responsible for the daily management of the company's financial affairs.

Contact Us

Hatnufa 3 st. , 7th Floor

Industrial Park

Yokneam, Israel

+972-54-3113699

Thanks for submitting!

bottom of page